The impact of parallel regulatory-HTA scientific advice on clinical development. Assessing the uptake of regulatory and HTA recommendations.
| Author | |
|---|---|
| Abstract | :
The "Parallel regulatory-HTA SA" (PSA) procedure allows manufacturers to receive simultaneous feedback from both EU regulators and HTA bodies on development plans for new medicines. |
| Year of Publication | :
2018
|
| Journal | :
British journal of clinical pharmacology
|
| Date Published | :
2018
|
| ISSN Number | :
0306-5251
|
| URL | :
http://dx.doi.org/10.1111/bcp.13524
|
| DOI | :
10.1111/bcp.13524
|
| Short Title | :
Br J Clin Pharmacol
|
| Download citation |